This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mezhir, J. J. Articles by Weichselbaum, R. R. Search for Related Content PubMed PubMed Citation Articles by Mezhir, J. J. Articles by Weichselbaum, R. R.

Ionizing Radiation Activates Late Herpes Simplex Virus 1 Promoters via the p38 Pathway in Tumors Treated with Oncolytic Viruses

Departments of ¹ Surgery and ² Radiation and Cellular Oncology and ³ The Marjorie B. Kovler Viral Oncology Laboratories, University of Chicago, Chicago, Illinois

Requests for reprints: Ralph R. Weichselbaum, Department of Radiation and Cellular Oncology, Center for Advanced Medicine, The University of Chicago Hospitals, Room 1329, Mail Code 9006, 5758 South Maryland Avenue, Chicago, IL 60637. Phone: 773-702-0817; Fax: 773-834-7233; E-mail: rrw{at}rover.uchicago.edu.

Ionizing radiation potentiates the oncolytic activity of attenuated herpes simplex viruses in tumors exposed to irradiation at specific time intervals by inducing higher virus yields. Cell culture studies have shown that an attenuated virus lacking the viral ₁34.5 genes underproduces late proteins whose synthesis depends on sustained synthesis of viral DNA. Here we report that ionizing radiation enhances gene expression from late viral promoters in transduced cells in the absence of other viral gene products. Consistent with this result, we show that in tumors infected with the attenuated virus, ionizing radiation increases 13.6-fold above baseline the gene expression from a late viral promoter as early as 2 hours after virus infection, an interval too short to account for viral DNA synthesis. The radiation-dependent up-regulation of late viral genes is mediated by the p38 pathway, inasmuch as the enhancement is abolished by p38 inhibitors or a p38 dominant-negative construct. The p38 pathway is not essential for wild-type virus gene expression. The results suggest that ionizing radiation up-regulates late promoters active in the course of viral DNA synthesis and provide a rationale for use of radiation to up-regulate cytotoxic genes introduced into tumor cells by viral vectors for cytoreductive therapy.

This article has been cited by other articles:

				C. Liu, J. N. Sarkaria, C. A. Petell, G. Paraskevakou, P. J. Zollman, M. Schroeder, B. Carlson, P. A. Decker, W. Wu, C. D. James, et al. Combination of Measles Virus Virotherapy and Radiation Therapy Has Synergistic Activity in the Treatment of Glioblastoma Multiforme Clin. Cancer Res., December 1, 2007; 13(23): 7155 - 7165. [Abstract] [Full Text] [PDF]

				J. Veerapong, K. A. Bickenbach, M. Y. Shao, K. D. Smith, M. C. Posner, B. Roizman, and R. R. Weichselbaum Systemic Delivery of {gamma}134.5-Deleted Herpes Simplex Virus-1 Selectively Targets and Treats Distant Human Xenograft Tumors That Express High MEK Activity Cancer Res., September 1, 2007; 67(17): 8301 - 8306. [Abstract] [Full Text] [PDF]

				G. Zhou and B. Roizman Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13{alpha}2 receptor PNAS, April 4, 2006; 103(14): 5508 - 5513. [Abstract] [Full Text] [PDF]